National Healthcare
132 hedge funds and large institutions have $456M invested in National Healthcare in 2023 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 38 increasing their positions, 55 reducing their positions, and 14 closing their positions.
9% more capital invested
Capital invested by funds: $418M → $456M (+$38.1M)
1.3% more ownership
Funds ownership: 46.83% → 48.13% (+1.3%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less funds holding
Funds holding: 136 → 132 (-4)
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
31% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 55
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$6.74M |
| 2 |
JP Morgan Chase
New York
|
+$5.37M |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$4.66M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.33M |
| 5 |
BlackRock
New York
|
+$2.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.94M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.49M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$2.47M |
| 4 |
E
Ergoteles
New York
|
-$2.23M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.96M |
NHC Hedge Fund Activity: Q2 2023 in Review
132 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in National Healthcare (NHC) for Q2 2023, worth a combined $456M — up 9.1% from $418M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of NHC and 10 opened new positions — a net loss of 4 holders — while 55 trimmed existing stakes and 38 added.
The largest buyer was Ameriprise, adding an estimated $6.74M. The largest seller was Vanguard Group, cutting an estimated $3.94M.
- 132 institutional investors held National Healthcare (NHC) as of Q2 2023, down from 136 in Q1 2023.
- Funds reported $456M of National Healthcare stock for Q2 2023, up 9.1% quarter-over-quarter.
- 10 funds opened new National Healthcare positions in Q2 2023 and 14 closed out, a net change of -4 holders.
- The largest National Healthcare buyer in Q2 2023 was Ameriprise, an estimated $6.74M added.
- The largest National Healthcare seller in Q2 2023 was Vanguard Group, an estimated $3.94M sold.
Based on aggregated 13F filings for Q2 2023.